Target intelligence / Profile preview

FSIP2 antisense RNA 1 (FSIP2-AS1)

Target
FSIP2-AS1
Molecular classification
Other (Antisense long non-coding RNA; lncRNA)
01

Overview

FSIP2 antisense RNA 1 (FSIP2-AS1) is an antisense long non-coding RNA that is transcribed from a region adjacent to the FSIP2 gene. Like other lncRNAs, FSIP2-AS1 is presumed to participate in gene regulatory processes—potentially affecting FSIP2 gene expression via antisense mechanisms—but its precise biological functions, disease associations, and molecular interactions remain largely uncharacterized in the published literature[3][10]. FSIP2-AS1 is listed with alternative names including FSIP2 antisense RNA 2 (FSIP2-AS2) and occurs in reference databases, such as NCBI Gene and Ensembl[10]. No evidence from search results supports FSIP2-AS1 as a pharmacological or therapeutic target, nor does current information connect it to well-established mechanisms in disease or drug response. In summary, FSIP2-AS1 is a non-coding antisense RNA gene with limited functional and clinical annotation; it is not considered a standard therapeutic target.

Other names
FSIP2 antisense RNA 1FSIP2-AS1FSIP2 antisense RNA 2FSIP2-AS2
02

Mechanism of action

Not applicable—no drugs or direct targeting mechanisms exist for FSIP2-AS1.

03

Biological functions

Gene regulation (likely involved in post-transcriptional regulation, but detailed functional characterization is not established in current literature)
04

Disease associations

Unknown or not established. No direct disease associations or roles as a biomarker are currently described.
05

Safety considerations

None reported or established in clinical literature.
06

Biomarkers

None established for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on FSIP2 antisense RNA 1 (FSIP2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FSIP2 antisense RNA 1 (FSIP2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call